Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lemaitre Vascular (LMAT) Shares Outstanding (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed Shares Outstanding for 16 consecutive years, with $24.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Shares Outstanding rose 1.01% to $24.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $24.4 million, a 1.01% increase, with the full-year FY2025 number at $24.4 million, up 1.01% from a year prior.
  • Shares Outstanding was $24.4 million for Q4 2025 at Lemaitre Vascular, roughly flat from $24.3 million in the prior quarter.
  • In the past five years, Shares Outstanding ranged from a high of $24.4 million in Q4 2025 to a low of $1.5 million in Q1 2021.
  • A 5-year average of $20.5 million and a median of $23.8 million in 2023 define the central range for Shares Outstanding.
  • Peak YoY movement for Shares Outstanding: plummeted 93.33% in 2023, then surged 1430.99% in 2024.
  • Lemaitre Vascular's Shares Outstanding stood at $1.6 million in 2021, then skyrocketed by 1421.36% to $23.7 million in 2022, then rose by 1.08% to $23.9 million in 2023, then increased by 1.01% to $24.2 million in 2024, then rose by 1.01% to $24.4 million in 2025.
  • Per Business Quant, the three most recent readings for LMAT's Shares Outstanding are $24.4 million (Q4 2025), $24.3 million (Q3 2025), and $24.2 million (Q2 2025).